Liu et al. demonstrated that upregulation of MRPL12 served as an independent risk factor and correlated with poor survival of breast cancer patients; MRPL12 knockdown markedly inhibited cell viability and migration in breast cancer [11]. This evidence concerns the gene MRPL12 and breast carcinoma.